Nanomedicine Explored at Molecular Imaging Summit

摘要

Nanotechnology is a rapidly evolving field with tremendous opportunities for applying technology in highly targeted ways. But for nanotechnology to be truly translated into meaningful benefits for patients, basic research in the laboratory must be supported by evidence-based medicine and predictable regulatory pathways.1 Molecular imaging plays a pivotal role in the assessment of health and environmental impacts of nanomaterials. One of the key goals of the Society of Nuclear Medicine's Center for Molecular Imaging Innovation and Translation (CMIIT, formerly the Molecular Imaging Center of Excellence) is to highlight and explore emerging technologies that may be novel, experimental, and possibly controversial.